VLUE vs XLV
iShares MSCI USA Value Factor ETF vs Health Care Select Sector SPDR Fund
- • XLV has the lower expense ratio at 0.08% vs 0.15% for VLUE.
- • VLUE pays a higher dividend yield (1.59%).
Side-by-side metrics
| Metric | VLUE | XLV |
|---|---|---|
Expense ratio Annual fee. Lower is better. | 0.15% | 0.08% |
Dividend yield Trailing 12-month yield. | 1.59% | 1.38% |
AUM Assets under management — bigger funds are typically more liquid. | $9.43B | $49.10B |
YTD return | 38.60% | 23.16% |
1-year return | — | — |
3-year return Annualized. | — | — |
5-year return Annualized. | — | — |
10-year return Annualized. | — | — |
Beta (3Y) Volatility relative to the market. Closer to 1 = market-like. | 1.23 | 0.41 |
P/E ratio | 15.38 | 30.63 |
Last price | $192.71 | $187.94 |
Inception | — | — |
Issuer | iShares | State Street |
VLUE top holdings
| MU | Micron Technology Inc | 20.21% |
| CSCO | Cisco Systems Inc | 4.15% |
| GM | General Motors Co | 3.89% |
| VZ | Verizon Communications Inc | 2.81% |
| T | AT&T Inc | 2.32% |
| PFE | Pfizer Inc | 1.93% |
| HPE | Hewlett Packard Enterprise Co | 1.79% |
| BAC | Bank of America Corp | 1.77% |
| F | Ford Motor Co | 1.77% |
| DIS | The Walt Disney Co | 1.75% |
XLV top holdings
| LLY | Eli Lilly and Co | 16.88% |
| JNJ | Johnson & Johnson | 9.80% |
| ABBV | AbbVie Inc | 7.76% |
| MRK | Merck & Co Inc | 5.49% |
| UNH | UnitedHealth Group Inc | 5.44% |
| TMO | Thermo Fisher Scientific Inc | 3.84% |
| AMGN | Amgen Inc | 3.75% |
| GILD | Gilead Sciences Inc | 3.15% |
| ABT | Abbott Laboratories | 2.74% |
| PFE | Pfizer Inc | 2.59% |
About VLUE
VLUE (iShares MSCI USA Value Factor ETF) is US stocks with attractive valuations vs fundamentals. Managed by iShares, the fund carries $9.4B in assets under management, an expense ratio of 0.15%, a dividend yield of 1.59%. Its largest holding is Micron Technology Inc (MU), which represents 20.2% of the portfolio. Real Estate is the fund's largest sector exposure at 1.6%.
About XLV
XLV (Health Care Select Sector SPDR Fund) is S&P 500 health care sector. Managed by State Street, the fund carries $49.1B in assets under management, an expense ratio of 0.08%, a dividend yield of 1.38%. Its largest holding is Eli Lilly and Co (LLY), which represents 16.9% of the portfolio. Healthcare is the fund's largest sector exposure at 100.0%.